COLL Collegium Pharmaceutical PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: COLL
- PE Ratio
The current PE ratio for Collegium Pharmaceutical stock as of May 9, 2025 is 21.24. This is calculated based on the current EPS of $1.36 and the stock price of $28.89 per share. The P/E ratio has an increase of 41% from the past four quarters average of 15.1.
COLL PE ratio history
The average historical PE ratio of Collegium Pharmaceutical for the last five years is 22.0. The current PE ratio of 21.24 is 3.5% below the historical average. Over the past five years, COLL's PE ratio was at its highest in the Sep 2023 quarter at 85.96, when the stock price was $22.35 and the EPS was $0.26. The lowest value was in the Sep 2021 quarter, when it reached 6.71 with a price of $19.74 and an EPS of $2.94.
Collegium Pharmaceutical PE ratio by year
Maximum annual decrease: -64.52% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 13.39 | -37.78% | $28.65 | $2.14 |
| 2023 | 21.52 | N/A | $30.78 | $1.43 |
| 2022 | N/A | N/A | $23.2 | -$0.74 |
| 2021 | 9.11 | -64.52% | $18.68 | $2.05 |
| 2020 | 25.68 | N/A | $20.03 | $0.78 |
| 2019 | N/A | N/A | $20.58 | -$0.68 |
| 2018 | N/A | N/A | $17.17 | -$1.19 |
| 2017 | N/A | N/A | $18.46 | -$2.47 |
| 2016 | N/A | N/A | $15.57 | -$3.88 |
| 2015 | N/A | N/A | $27.5 | -$1.48 |
| 2014 | N/A | N/A | N/A | -$22.72 |
| 2013 | N/A | N/A | N/A | -$4.06 |
Collegium Pharmaceutical PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 21.95 | 63.93% | $29.85 | $1.36 |
| Dec 2024 | 13.39 | -6.1% | $28.65 | $2.14 |
| Sep 2024 | 14.26 | 34.15% | $38.64 | $2.71 |
| Jun 2024 | 10.63 | -23.03% | $32.2 | $3.03 |
| Mar 2024 | 13.81 | -35.83% | $38.82 | $2.81 |
| Dec 2023 | 21.52 | -74.97% | $30.78 | $1.43 |
| Sep 2023 | 85.96 | N/A | $22.35 | $0.26 |
| Jun 2023 | N/A | N/A | $21.49 | -$0.34 |
| Mar 2023 | N/A | N/A | $23.99 | -$0.87 |
| Dec 2022 | N/A | N/A | $23.2 | -$0.74 |
| Sep 2022 | N/A | N/A | $16.02 | -$1.22 |
| Jun 2022 | N/A | N/A | $17.72 | -$1 |
| Mar 2022 | 16.83 | 84.74% | $20.36 | $1.21 |
| Dec 2021 | 9.11 | 35.77% | $18.68 | $2.05 |
| Sep 2021 | 6.71 | -13.75% | $19.74 | $2.94 |
COLL average PE ratio chart
Currently, COLL's PE ratio is below the 3, 5 and 10-year averages.
COLL PE vs peers
COLL's PE ratio is lower than its peer stock SUPN, but it is greater than UTHR's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| UTHR UNITED THERAPEUTICS Corp | 11.13 | $13.6B |
| COLL Collegium Pharmaceutical Inc | 21.24 | $928.59M |
| SUPN Supernus Pharmaceuticals Inc | 28.05 | $1.77B |
| LPCN Lipocine Inc | N/A | $17.52M |
Frequently asked questions
What is Collegium Pharmaceutical's PE ratio?
COLL stock has a price to earnings ratio of 21.24 as of May 9, 2025.
What is the 3-year average PE ratio for Collegium Pharmaceutical (COLL)?
The average PE ratio for COLL stock over the past 3 years is 25.93.
What is the 5-year average PE ratio for Collegium Pharmaceutical (COLL)?
The average PE ratio for COLL stock over the past 5 years is 22.0.
What is the highest PE ratio for COLL?
In the last five years, the Sep 2023 quarter recorded the highest quarterly PE ratio at 85.96.
How does the current PE ratio for COLL compare to its historical average?
The current price to earnings ratio of COLL is 3.5% lower than the 5-year historical average.
How is COLL's PE ratio calculated (Collegium Pharmaceutical PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (May 9, 2025), Collegium Pharmaceutical's stock price is $28.89. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.36. Therefore, Collegium Pharmaceutical's P/E ratio for today is 21.24. PE RATIO(21.24) = STOCK PRICE($28.89) / TTM EPS($1.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.